Xtant Medical Holdings, Inc.
XTNTNYSECIK 1453593HealthcareFiscal year ends Dec 31
Reports and events: 545 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2017-08-2916:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001552781-17-000505 |
| 2017-08-1716:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001144204-17-043872 |
| 2017-08-1415:46 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001144204-17-043085 |
| 2017-08-1009:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000470 |
| 2017-08-0913:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000465 |
| 2017-07-2416:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000430 |
| 2017-07-2016:08 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001552781-17-000421 |
| 2017-07-0717:03 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001552781-17-000375 |
| 2017-05-3016:39 ET | SC 13D | Ownership report, active investor | 0000947871-17-000412 |
| 2017-05-2616:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001552781-17-000333 |
| 2017-05-1607:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000323 |
| 2017-05-1515:26 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001144204-17-027384 |
| 2017-05-1209:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001552781-17-000317 |
| 2017-05-1018:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000303 |
| 2017-05-0516:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000296 |
| 2017-05-0416:13 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001552781-17-000283 |
| 2017-05-0212:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000274 |
| 2017-04-2507:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000232 |
| 2017-04-2407:51 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001552781-17-000225 |
| 2017-04-1916:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001552781-17-000213 |
| 2017-04-0617:18 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000180 |
| 2017-03-2912:49 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001144204-17-017200 |
| 2017-03-1019:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001552781-17-000111 |
| 2017-03-0216:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000098 |
| 2017-02-2316:05 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000081 |
| 2017-02-1517:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001552781-17-000077 |
| 2017-02-0116:48 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001144204-17-005385 |
| 2017-01-2307:55 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001552781-17-000046 |
| 2017-01-2016:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001144204-17-003181 |
| 2017-01-1908:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000031 |
| 2017-01-1817:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-17-002749 |
| 2017-01-1317:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-17-000022 |
| 2017-01-1115:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001552781-17-000014 |
| 2017-01-0616:11 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-17-001099 |
| 2016-11-2310:58 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-16-002109 |
| 2016-11-1715:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-16-002105 |
| 2016-11-1513:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-16-002101 |
| 2016-11-1411:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-16-002097 |
| 2016-11-1016:44 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001144204-16-133350 |
| 2016-11-0909:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-16-002069 |
| 2016-11-0716:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001552781-16-002058 |
| 2016-11-0117:15 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-16-002026 |
| 2016-10-2814:16 ET | S-1/A | Registration statement, amended | 0001144204-16-130161 |
| 2016-10-2114:17 ET | S-1/A | Registration statement, amended | 0001144204-16-128907 |
| 2016-10-1808:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-16-001998 |
| 2016-10-1716:15 ET | S-1/A | Registration statement, amended | 0001144204-16-128356 |
| 2016-10-1107:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001552781-16-001979 |
| 2016-10-0612:24 ET | S-1/A | Registration statement, amended | 0001144204-16-127172 |
| 2016-10-0611:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-16-127142 |
| 2016-09-2815:52 ET | S-1/A | Registration statement, amended | 0001144204-16-125750 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.